The cancer institute of the Saint-Luc university hospital in Brussels, the teaching hospital of UCLouvain opened in 1976, and a full member of the Organisation of European Cancer Institutes.
The Institut Roi Albert II is the cancer and haematology institute of the Cliniques universitaires Saint-Luc in Woluwe-Saint-Lambert, Brussels, the university hospital of UCLouvain that opened in 1976. It brings the hospital's oncology, haematology, radiotherapy and surgical cancer services together with the university's research groups. It is a full member of the Organisation of European Cancer Institutes (OECI); its representative on the OECI list is Philippe Leroy.
From OpenAlex, oncology works in the last five years (2022 to 2026, current year in progress); counted on 2026-10-08.
Matched to Cliniques Universitaires Saint-Luc, including child institutions. 341 works · 4,612 citations · 79% open access · 17% clinical trials · 2% reviews.
Brussels oncologist who led KEYNOTE-412, the trial that tested adding pembrolizumab to chemoradiotherapy for locally advanced head and neck cancer.
Philippe Leroy represents the King Albert II Cancer Institute of Cliniques universitaires Saint-Luc in the Organisation of European Cancer Institutes, which lists the centre among its full members in Belgium.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/